Establishes the New Jersey Pharmacogenomics Commission to study the impact of genetic makeup on medication effectiveness.
The New Jersey Pharmacogenomics Commission is established to examine pharmacogenomics, the study of how a person's genetic makeup affects medication effectiveness and toxicity. The commission will explore costs, benefits, applications, and education methods related to pharmacogenomics. It will hold public hearings and submit a report with recommendations to the Governor and Legislature. The commission will expire after submitting its report.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.